Management of levonorgestrel-releasing intrauterine system (LNG-IUS) uterine perforation

By Margarit Lavinia   Griffiths AN   Vine SJ  

Journal of Obstetrics & Gynaecology, Vol. 24, Iss. 5, 2004-08 ,pp. : 586-587

Informa Healthcare

Access to resources Recommend Favorite

Comparison of the effects of the levonorgestrel-releasing intrauterine system (Mirena®) and depot-medroxyprogesterone acetate (Depo-Provera®) on subendometrial microvascularisation and uterine artery blood flow

By Dane Banu   Akca Aysu   Dane Cem   Evcimen Serap   Cetin Ahmet  

The European Journal of Contraception and Reproductive Health Care, Vol. 14, Iss. 3, 2009-06 ,pp. : 240-244

Informa Healthcare

Access to resources Recommend Favorite

Severe seborrhoeic dermatitis: Side-effect of the Mirena intra-uterine system

By Karri K.   Mowbray D.   Adams S.   Rendal J. R. S.  

The European Journal of Contraception and Reproductive Health Care, Vol. 11, Iss. 1, 2006-03 ,pp. : 53-54

Informa Healthcare

Access to resources Recommend Favorite

Levonorgestrel hormone releasing intrauterine system (Mirena®) as a contraceptive in egg donors: case report

By Kailasam C.   Akande V.   Gordon U.  

Journal of Assisted Reproduction and Genetics, Vol. 22, Iss. 3, 2005-03 ,pp. : 137-140

Springer Publishing Company

Access to resources Recommend Favorite

The levonorgestrel intrauterine system (Mirena®) for treatment of idiopathic menorrhagia. Assessment of quality of life and satisfaction

By Lete I.   Obispo C.   Izaguirre F.   Orte T.   Rivero B.   Cornellana M. J.   Bermejo I.  

The European Journal of Contraception and Reproductive Health Care, Vol. 13, Iss. 3, 2008-01 ,pp. : 231-237

Informa Healthcare

Access to resources Recommend Favorite